Download
s12889-021-12050-7.pdf 1,06MB
WeightNameValue
1000 Titel
  • Effectiveness of the German disease management programs: quasi-experimental analyses assessing the population-level health impact
1000 Autor/in
  1. Burns, Jacob |
  2. Kurz, Christoph |
  3. Laxy, Michael |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-11-15
1000 Erschienen in
1000 Quellenangabe
  • 21(1):2092
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12889-021-12050-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591814/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!In 2002-2003 disease management programs (DMPs) for type 2 diabetes and coronary heart disease were introduced in Germany to improve the management of these conditions. Today around 6 million Germans aged 56 and older are enrolled in one of the DMPs; however, their effect on health remains unclear.!##!Methods!#!We estimated the impact of German DMPs on circulatory and all-cause mortality using a synthetic control study. Specifically, using routinely available data, we compared pre and post-intervention trends in mortality of individuals aged 56 and older for 1998-2014 in Germany to trends in other European countries.!##!Results!#!Average circulatory and all-cause mortality in Germany and the synthetic control was 1.63 and 3.24 deaths per 100 persons. Independent of model choice, circulatory and all-cause mortality decreased non-significantly less in Germany than in the synthetic control; for the model with a 3 year time lag, for example, by 0.12 (95%-CI: - 0.20; 0.44) and 0.22 (95%-CI: - 0.40; 0.66) deaths per 100 persons, respectively. Further main analyses, as well as sensitivity and subgroup analyses supported these results.!##!Conclusions!#!We observed no effect on circulatory or all-cause mortality at the population-level. However, confidence intervals were wide, meaning we could not reject the possibility of a positive effect. Given the substantial costs for administration and operation of the programs, further comparative effectiveness research is needed to clarify the value of German DMPs for type 2 diabetes and CHD.
1000 Sacherschließung
lokal Europe [MeSH]
lokal Coronary Disease [MeSH]
lokal Mortality
lokal Humans [MeSH]
lokal Coronary disease
lokal Diabetes Mellitus, Type 2/therapy [MeSH]
lokal Diabetes mellitus, type 2
lokal Disease Management [MeSH]
lokal Disease management
lokal Research Article
lokal Germany/epidemiology [MeSH]
lokal Program evaluation
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-4015-6862|https://orcid.org/0000-0001-9498-8002|https://orcid.org/0000-0001-8775-7417
1000 Hinweis
  • DeepGreen-ID: 9af9e9479846499481b6ba3ee0c0c9b8 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6462619.rdf
1000 Erstellt am 2023-11-15T13:33:20.461+0100
1000 Erstellt von 322
1000 beschreibt frl:6462619
1000 Zuletzt bearbeitet 2023-11-30T20:10:22.287+0100
1000 Objekt bearb. Thu Nov 30 20:10:22 CET 2023
1000 Vgl. frl:6462619
1000 Oai Id
  1. oai:frl.publisso.de:frl:6462619 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source